Human papillomavirus and the development of non-melanoma skin cancer

Journal of Clinical Pathology

Volumn 52, Issue 4, 1999, Pages 249-253

  Harwood, Catherine A ^a   McGregor, Jane M ^a   Proby, Charlotte M ^a   Breuer, Judith ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Human papillomavirus; Non melanoma skin cancer

Indexed keywords

PROTEIN P53;

ARTICLE; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; IMMUNE DEFICIENCY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOGENESIS; VIRUS CARCINOGENESIS; VIRUS CLASSIFICATION; WART VIRUS;

EID: 0032938935     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.4.249     Document Type: Article

References (51)

1. 1 Ko CB, Walton S, Keczkes K, et al. The emerging epidemic of skin cancer. Br J Dermatol 1994;130:269-72.
2. 2 Leigh IM, Newton Bishop JA, Kripke ML. Skin cancer. In: Leigh IM, Newton Bishop JA, Kripke ML, eds. Cancer surveys, vol 26. New York: Cold Spring Harbour Laboratory Press, 1996:1-6.
3. 3 Frost CA, Green AC. Epidemiology of solar keratosis. Br J Dermatol 1994;131:455-64.
4. 4 Ziegler A, Lefell DJ, Kunala S, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 1993;90:4216-20.
5. 5 Rees J. Genetic alterations in non-melanoma skin cancer. J Invest Dermatol 1994;103:747-50.
6. 6 Zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
7. 7 Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 1995;131:1312-18.
8. 8 Shamanin V, Glover M, Rausch G, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994; 54:4610-13.
9. 9 Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in non-melanoma skin cancers from renal transplant recipients and non-immunosuppressed patients. J Natl Cancer Inst 1996;88:802-11.
10. 10 Berkhout RJM, Tieben LM, Smits HL, et al. Nested PCR approach to detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 115;33:690-5.
11. 11 de Jong-Tieben LM, Berkhout RJM, Smits HL, et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from transplant recipients. J Invest Dermatol 1995;105:367-71.
12. 12 De Villiers E-M, Lavergne D, Mclaren K, et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997;73:356-61.
13. 13 de Villiers E-M. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994;186:1-12.
14. 14 Chan SY, Delius H, Halpern AL, et al. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny and taxonomy. J Virol 1995;69:3074-83.
15. 15 Lewandowsky F, Lutz W. Ein Fal einer bisher nich beschrieben Hauterkrankung (epidermodysplasia verruciformis). Arch Dermatol Syphilol 1922;141:193-203.
16. 16 Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. In: Ciba Foundation Symposium 1984;120:157-74.
17. 17 Cooper KD, Androphy EJ, Lowy D, et al. Antigen presentation and T cell activation in epidermodysplasia verruciformis. J Invest Dermatol 1990;94:769-76.
18. 18 Woodworth CD, Doniger J, DiPaolo JA. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J Virol 1989;63:159-64.
19. 19 Iftner T, Bierfelder S, Csapo Z, et al. Involvement of the human papillomavirus type 8 genes E6 and H7 in transformation and replication. J Virol 1988;62:3655-61.
20. 20 Kiyono T, Nagashima K, Ishibashi M. The primary structure of major viral RNA in a rat cell line transfected with type 47 human papillomavirus DNA and the transforming activity of its cDNA and E6 gene. Virology 1989;173:551-65.
21. 21 Steger G, Pfister H. In vitro expressed HPV8 E6 protein does not bind p53. Arch Virol 1992;125:355-60.
22. 22 Seeberger R, Haugen T, Turek L, et al. An enhancer of human papillomavirus type 8 is trans-activated by the bovine papillomavirus type 1 E2 function. In: Steinberg BM, Brandsma JL, Taichman LB, eds. Papillomaviruses: cancer cells, vol 5. New York: Cold Spring Harbor Laboratory, 1987:33-8.
23. 23 May M, Grassman K, Pfister H, et al. Transcriptional silencer of the HPV 8 later promotor interacts alternatively with the viral transactivator E2 or with cellular factor. J Virol 1994;68:3612-19.
24. 24 Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971;ii:1282-3.
25. 25 Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964 1986. Int J Cancer 1995;60:183-9.
26. 26 Shiel A, Flavel S, Disney A, et al. Cancer development in patients progressing to dialysis and renal transplantation. Transplant Proc 1985;17:1685-8.
27. 27 Hardie IR, Strong RW, Hartley LC, et al. Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 1989;87:177-83.
28. 28 Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990;49:506-9.
29. 29 London NJ, Farmery SM, Will EJ, et al. Risk of neoplasia in renal transplant patients. Lancet 1995;346:403-6.
30. 30 Boyle J, McKie R, Briggs J, et al. Cancer, warts and sunshine in renal transplant recipients: a case control study. Lancet 1984;i:702-5.
31. 31 Blessing K, McClaren KM, Benton EC, et al. Histopathology of skin lesions in renal allograft recipients: an assessment of viral features and dysplasia. Histopathology 1989;14:129-39.
32. 32 Benton C, Shahidullah H, Hunter JAA. Human papillomavirus in the immunosuppressed. Papillomavirus Rep 1992;2: 23-6.
33. 33 Glover MT, Proby CM, Leigh IM. Skin cancer in renal transplant patients. Cancer Bull 1993;45:220-4.
34. 34 McGregor JM, Proby CM. The role of papillomaviruses in human non-melanoma skin cancer. In: Leigh IM, Newton Bishop JA, Kripke ML, eds. Cancer surveys: skin cancer, vol 26. New York: Cold Spring Harbour Laboratory Press, 1996:219-36.
35. 35 Proby C, Storey A, McGregor J, et al. Does human papillomavirus infection play a role in non-melanoma skin cancer? Papillomavirus Rep 1996;7:53-60.
36. 36 Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
37. 37 Studniberg HM, Weller P. PUVA, UVB, psoriasis and non-melanoma skin cancer. J Am Acad Dermatol 1993;29:1013-22.
38. 38 Young AR. Photocarcinogenecity of psoralens used in PUVA treatment: present status in mouse and man. J Photochem Photobiol B:Biol 1990;6:237-47.
39. 39 Nataraj AJ, Wolf P, Cerroni L, et al. p53 Mutation in squamous cell carcinomas from psoriasis patients treated with psoralen + UVA (PUVA). J Invest Dermatol 1997;109: 238-43.
40. 40 Ullrich SE. Systemic immunosuppression of cell-mediated immune reactions by a monofunctional psoralen plus ultraviolet A radiation. Photodermatol Photoimmunol Photomed 1991;8:116-22.
41. 41 Kripke ML, Morison WL, Parrish JA. Systemic suppression of contact hypersensitivity in mice by psoralen plus UVA radiation (PUVA). J Invest Dermatol 1983;81:87-92.
42. 42 Harwood CA, Spink PJ, Surentheran T, et al. Detection of human papillomavirus DNA in PUVA-associated non-melanoma skin cancers. J Invest Dermatol 1998;111:123-7.
43. 43 Weinstock MA, Coulter S, Bates J, et al. Human papillomavirus and widespread cutaneous carcinoma after PUVA photochemotherapy. Arch Dermatol 1995;131:701-4.
44. 44 Rubben A, Baron JM, Grussendorf-Conen E-I. Demonstration of human papillomavirus type 16-related DNA and absence of detectable p53 gene mutations in widespread cutaneous squamous cell carcinomas after oral psoralen with UV-A treatment. Arch Dermatol 1996;132:1257-9.
45. 45 Bayle-Lebey P, Labadies P, Basset-Seguin N, et al. Carcinomes cutanés et papillomavirus 5. Révélation lors d'une photochimiothérapie UVA prolongée. Ann Dermatol Venereol 1994;121:496-8.
46. 46 Hirt L, Hirsch-Behnam A, de Villiers E-M. Nucleotide sequence of human papillomavirus (HPV) type 41: an unusual HPV type without typical E2 binding site consensus sequence. Virus Res 1990;18:179-90.
47. 47 Penneys NS. Cutaneous viral disease in AIDS. In: Penneys NS, ed. Skin manifestations of AIDS, 2nd ed. London: Martin Dunitz, 1995:84-91.
48. 48 Milburn PB, Brandsma JL, Goldsman CI, et al. Disseminated warts and evolving squamous cell carcinoma in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1988;19:401-5.
49. 49 Berger TG, Sawchuk WS, Leonardi C, et al. Epidermodysplasia verruciformis-associated papiliomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol 1991;124:79-83.
50. 50 Maurer TA, Vin Christian K, Kerschmann RL, et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol 1997;133:577-83.
51. 51 International Agency for Research on Cancer. IARC monographs on the evaluation of the carcinogenic risk to humans, vol 64. Human papillomaviruses. Lyons: International Agency for Research on Cancer, 1995:196-212.